AstraZeneca Selects Cambridge, UK for New Global R&D Center and Corporate HQ

The multimillion investment in a facility in Cambridge is part of the company’s move to create strategic global R&D centers in the UK, US and Sweden.
Jun 19, 2013
By BioPharm International Editors